IKT EBITDA
Inhibikase Therapeutics Inc · EBITDA
IKT EBITDA
Latest reported-$62.34Mperiod ending
IKT TTM EBITDA (-$1.21M → -$62.34M)
TTM EBITDA
High-resolution chart · PNG
IKT ebitda history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | EBITDA (USD) |
|---|---|
| -62,343,041 | |
| -53,918,350 | |
| -53,287,726 | |
| -52,280,279 | |
| -44,814,264 | |
| -38,600,763 | |
| -27,493,614 | |
| -19,538,976 | |
| -18,356,094 | |
| -19,021,817 | |
| -18,851,485 | |
| -18,954,128 | |
| -18,858,394 | |
| -13,239,632 | |
| -8,766,897 | |
| -4,492,882 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| -1,259,072 | |
| -1,259,072 | |
| -1,205,160 | |
| -1,205,160 |